![]() Assignors: Compass Pathways Limited Priority to US17/172,411 priority patent/US11149044B2/en Application granted granted Critical Publication of US10954259B1 publication Critical patent/US10954259B1/en Publication of US20210087212A1 publication Critical patent/US20210087212A1/en Priority to US17/228,936 priority patent/US11180517B2/en Priority to US17/531,159 priority patent/US11447510B2/en First worldwide family litigation filed litigation Critical (B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License. Assignors: NICHOLS, DAVID E., LONDESBROUGH, DEREK JOHN, BROWN, CHRISTOPHER, Patil, Hemant Kashinath, MOORE, GILLIAN, NORTHEN, JULIAN SCOTT Assigned to COMPASS PATHFINDER LIMITED reassignment COMPASS PATHFINDER LIMITED CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). ![]() Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Family has litigation Priority claimed from GB1716505.1 external-priority Priority to US17/116,739 priority Critical patent/US10954259B1/en Application filed by Compass Pathfinder Ltd filed Critical Compass Pathfinder Ltd Assigned to Compass Pathways Limited reassignment Compass Pathways Limited ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Original Assignee Compass Pathfinder Ltd Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.) Nichols Current Assignee (The listed assignees may be inaccurate. ( en Inventor Derek John Londesbrough Christopher Brown Julian Scott Northen Gillian Moore Hemant Kashinath Patil David E. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.) Active Application number US17/116,739 Other versions US20210087212A1 Google Patents Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their useĭownload PDF Info Publication number US10954259B1 US10954259B1 US17/116,739 US202017116739A US10954259B1 US 10954259 B1 US10954259 B1 US 10954259B1 US 202017116739 A US202017116739 A US 202017116739A US 10954259 B1 US10954259 B1 US 10954259B1 Authority US United States Prior art keywords psilocybin polymorph crystalline stage reaction Prior art date Legal status (The legal status is an assumption and is not a legal conclusion. Google Patents US10954259B1 - Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use US10954259B1 - Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
0 Comments
Leave a Reply. |